Advertisement

---

Health Business news
2017-11-16
Liquid Biopsy Market, 2025

Liquid Biopsy Market, 2025



DUBLIN, November 16, 2017 /PRNewswire/ --

The "Liquid Biopsy Market: 2017-2025" report has been added to Research and Markets' offering. A biopsy is the most common, definitive medical procedure used for cancer diagnosis and treatment monitoring. Tissue biopsy in specific is the widely followed procedure to detect cancer because of its accuracy. However, the major drawback for tissue based diagnosis approach is its involvement of invasive surgical procedures, which in many instances preclude the regular treatment monitoring and sometimes the initial diagnosis too.

The search for better minimal invasive diagnostic procedures to aid regular monitory of the patient's response towards the treatment, gave birth to liquid biopsy tests. In recent years the impressive research on cancer biomarkers presence in biological fluids such as blood, which can be collected through minimal invasive techniques yielded promising results to develop better minimal invasive diagnostics procedures which was later named as liquid biopsies.

Liquid biopsy is a minimal invasive medical procedure with the ability to detect presence of molecular cancer biomarkers in the biological fluids. The derived test results help doctors in deciding the further steps in treatment of patient for cancer. The test principally involves the use samples of biological fluids such as blood, urine, serum, and saliva, among others and then enrichment of the samples using different techniques such as Next generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) to detect the mutations known to cause cancer.

The liquid biopsy market is expected to grow at near double digit annual growth rate. Abilities of liquid biopsy such as minimal invasiveness, possibility of continuous monitory of patient's response towards treatment, and monitory of clonal mutations, combined with growing prominence for precision medicine have fueled the growth of liquid biopsy market.

The research study comprises of in-depth analysis of market trends and market size through different approaches. The entire market has been segmented and estimated in five different approaches namely by product & services, by biomarker and technology, by cancer type, by end users, and by geography.

Key Topics Covered:

1 EXECUTIVE SUMMARY1.1 Introduction1.2 Market Overview2 REPORT SCOPE AND METHODOLOGY3 MARKET DYNAMICS

2.1 Market Overview2.2 Drivers2.3 Restraints2.4 Opportunities2.5 Industry Analysis - Porter's

4 LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE4.1 OVERVIEW4.1.1. Market size and forecast4.2 KITS & REAGENTS4.2.1. Key market trends4.2.2. Growth factors and opportunities4.2.3. Market size and forecast4.3 PLATFORMS & INSTRUMENTS4.3.1. Key market trends4.3.2. Growth factors and opportunities4.3.3. Market size and forecast4.4 SERVICES4.4.1. Key market trends4.4.2. Growth factors and opportunities4.4.3. Market size and forecast5 LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER using different technologies such as NGS and PCR microarrays5.1 OVERVIEW5.1.1. Market size and forecast5.2 CIRCULATING TUMOR CELL (CTC)5.2.1. Market size and forecast5.3 CIRCULATING TUMOR DNA (CTDNA)5.3.1. Market size and forecast5.4 EXTRACELLULAR VESICLES (EVS)5.4.1. Market size and forecast5.5 OTHER BIOMARKERS5.5.1. Market size and forecast6 LIQUID BIOPSY MARKET, BY CANCER TYPE6.1 OVERVIEW6.1.1. Market Size and Forecast6.2 LUNG CANCER6.2.1. Market size and forecast6.3 BREAST CANCER6.3.1. Market size and forecast6.4 COLORECTAL CANCER6.4.1. Market size and forecast6.5 PROSTATE CANCER6.5.1. Market size and forecast6.6 LIVER CANCER6.6.1. Market size and forecast6.7 OTHER CANCERS6.7.1. Market size and forecast

7 LIQUID BIOPSY MARKET, BY END USER7.1 OVERVIEW7.1.1. Market size and forecast7.2 HOSPITAL AND LABORATORY7.2.1. Market size and forecast7.3 GOVERNMENT AND ACADEMIC RESEARCH CENTERS7.3.1. Market size and forecast

8 COMPETITIVE LANDSCAPE

9 LIQUID BIOPSY MARKET, BY GEOGRAPHY

10 COMPANY PROFILES ANGLE plc
Adaptive Biotechnologies
Bio-Rad Laboratories Inc.
Biocept Inc.
CareDx
Cynvenio Biosystems, Inc.
Epic Sciences
F.Hoffmann-La Roche AG
Genomic Health
Guardant Health, Inc.
Illumina, Inc.
JOHNSON& JOHNSON
MDxHealth, Inc.
Menarini Silicon Biosystems, Inc.
Myriad Genetics, Inc.
Natera, Inc.
NeoGenomics Laboratories, Inc.
QIAGEN
RainDance Technologies, Inc.
Sysmex Corporation
Thermo Fisher Scientific
Trovagene Inc.
For more information about this report visit https://www.researchandmarkets.com/research/p9h472/liquid_biopsy

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716




Prev Article
Next Article

> Article Date par Research and Markets

Read: 7 views

Notes :

Source : PRN-International Desk

Advertisement

Related content

: Latest news

Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers